|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| REVENUE | |||||
| COST OF REVENUE | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSES | |||||
| Selling and marketing expenses | |||||
| General and administrative expenses | |||||
| Total Operating Expenses | |||||
| OPERATING (LOSS)/INCOME | |||||
| Overprovision of prior year income tax | |||||
| Shares guarantee income | |||||
| Interest income | |||||
| Total Non-Operating Income | |||||
| NON-OPERATING EXPENSE | |||||
| Amortization of debt discounts | |||||
| Loss on conversion of accounts payable to common stock | |||||
| Change in fair value of derivative liability | |||||
| Derivative expense | |||||
| Interest expense | |||||
| Nonrelated Party | |||||
| Total Non-Operating Income (Expenses) | |||||
| Amortization of intangible assets | |||||
| Impairment of intangible assets | |||||
| Loss on write-off of investment | |||||
| Impairment loss – amount due from a director | |||||
| Impairment loss – other receivables | |||||
| Loss on investments at fair value, net | |||||
| Total Non-Operating Expense | |||||
| NET INCOME (LOSS) FROM OPERATIONS BEFORE PROVISION FOR INCOME TAXES | |||||
| NET (LOSS)/INCOME FROM OPERATIONS BEFORE INCOME TAX EXPENSE | |||||
| Income tax benefit/(expense) | |||||
| NET (LOSS)/INCOME | |||||
| NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST | |||||
| NET (LOSS)/INCOME ATTRIBUTABLE TO CONTROLLING INTEREST | |||||
| Foreign currency translations adjustment | |||||
| Continuing operations basic | |||||
| Net (loss)/income per share - basic | |||||
| Net (loss)/income per share - diluted | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...